• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCrime

Ivy League Doctor Gets 4 Years in Prison for Insys Opioid Kickbacks

By
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Bloomberg
Bloomberg
Down Arrow Button Icon
March 10, 2018, 12:51 PM ET

A Rhode Island doctor who took kickbacks from Insys Therapeutics Inc. officials for prescribing the company’s highly addictive liquid version of the opioid painkiller Fentanyl was sentenced to more than four years in prison.

Jerrold Rosenberg, who lost his medical license and was ousted from his post as a Brown University professor, pleaded guilty to taking more than $188,000 in kickbacks disguised as speaker fees and creating false patient records to dupe insurers into covering Insys’s Subsys pain medication.

“You in effect sold your medical license to a pharmaceutical company,” U.S. District Judge John J. McConnell Jr. said Friday in federal court. “That’s intolerable.” The judge sentenced him to 51 months and ordered restitution of $754,000.

Rosenberg is the fourth doctor jailed over Insys bribes following a federal probe that resulted in the indictment of billionaire founder and Chief Executive Officer John Kapoor and six other executives. The group was charged with orchestrating an elaborate scheme to bribe doctors and defraud health-care providers.

Federal prosecutors told the court Rosenberg ignored and bullied patients who resisted staying on the powerful pain-killing spray. At least one of Rosenberg’s patients suffered an overdose and was “near death” as a result of his wrongdoing, the government said in court filings.

‘Grave Betrayal’

Rosenberg’s son was an Insys sales representative for a year and made “substantial commissions” from his father’s willingness to prescribe the drug, according to prosecutors. The son wasn’t charged in the case.

“The doctor’s conduct showed that he set his financial gain above his patients’ interests,” prosecutors said. “It represented a grave betrayal of the duty every physician owes to his or her patients.’’

In a seven-page statement to the court, Rosenberg, 63, recounted his medical career and apologized for his crimes. “I have let a lot of people down including myself,” the doctor said. “I committed errors in judgment and allowed my integrity to be compromised.”

In February, Michigan pain-clinic doctor Gavin Awerbuch was sentenced to more than two years in prison after admitting he took sham speaker fees from Insys for prescribing Subsys for no legitimate medical purpose.

Alabama pain clinic doctor John Couch was sentenced last year to 20 years for racketeering after a jury found he took kickbacks for prescribing Subsys. Couch’s partner, Xiulu Ruan, also was sentenced to 21 years in prison for his role in the scheme.

The government contends that when Kapoor saw the bribes were generating more Subsys sales, he pumped more money into speakers’ fees. Prosecutors claim that Kapoor “tightly controlled’’ the scheme.

Kapoor, who is facing racketeering and conspiracy charges, is slated to go to trial in 2019. He and the other former Insys executives have pleaded not guilty to the charges.

The cases are U.S. v. Rosenberg, 17-00009, U.S. District Court, Rhode Island, and U.S. v. Babich, 16-cr-10343, U.S. District Court, Massachusetts.

 

About the Author
By Bloomberg
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

HealthHealth
It’s not just vaccines. Parents are refusing other routine preventive care for newborns—even protection from severe bleeding and blindness
By Laura Ungar and The Associated PressMarch 21, 2026
3 hours ago
Healthmeal delivery
The 6 Best Gluten-Free Meal Delivery Services of 2026: Nutritionist Approved
By Emily PharesMarch 20, 2026
1 day ago
Healthmeal delivery
Home Chef Meal Delivery Review (2026): Taste Tester Approved
By Christina SnyderMarch 20, 2026
1 day ago
Healthmeal delivery
The 4 Best Frozen Meal Delivery Services (2026): Personally Taste Tested
By Christina SnyderMarch 20, 2026
1 day ago
A podium with a sign reading "save healthcare" stands in front of the U.S. Capitol building.
Healthaffordability
‘Sometimes I don’t even take my medicine’: Americans are choosing between insulin and buying gas following Trump’s ACA cuts
By Ali Swenson and The Associated PressMarch 19, 2026
2 days ago
HealthDietary Supplements
The 4 Best Turmeric Supplements (2026): Expert Approved
By Emily PharesMarch 19, 2026
2 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.